Opioid Conversion Calculator
Convert opioid doses using equianalgesic ratios. Select source opioid, dose, and target opioid for equivalent dose with cross-tolerance adjustment and charts.
Half-life: 2–4 hours
Half-life: 3–4.5 hours
When switching opioids, reduce dose by 25–50% due to incomplete cross-tolerance. Default 0%.
About This Calculator
The Opioid Conversion Calculator converts doses between different opioid medications using equianalgesic conversion ratios. This tool helps healthcare professionals perform safe opioid rotation — switching a patient from one opioid to another while maintaining equivalent pain relief. It supports the most commonly prescribed opioids across oral, intravenous, subcutaneous, and transdermal routes of administration, including morphine, oxycodone, hydromorphone, codeine, tramadol, fentanyl, buprenorphine, diamorphine, and alfentanyl.
Each opioid and route combination has an established equianalgesic ratio relative to 10 mg of intravenous (IV) morphine, which serves as the reference standard. For example, 30 mg of oral morphine equals 10 mg IV morphine due to approximately 30% oral bioavailability. Similarly, 15 mg of oral oxycodone, 4 mg of oral hydromorphone, and 300 mg of oral codeine are each equivalent to 10 mg IV morphine. The calculator applies the formula: Target dose = Source dose × (Target equivalence factor / Source equivalence factor) to determine the equivalent dose.
Incomplete Cross-Tolerance
When switching between different opioids, patients may not have complete tolerance to the new opioid — a phenomenon called incomplete cross-tolerance. Clinical guidelines recommend reducing the calculated equivalent dose by 25-50% when performing opioid rotation to reduce the risk of overdose and respiratory depression. The calculator applies this reduction when a non-zero cross-tolerance percentage is entered. After the initial conversion, the dose should be titrated based on the patient's response and pain levels.
Regional Notes
Global: Equianalgesic conversion ratios are derived from published clinical studies and are generally consistent across international medical guidelines. Always verify against local formularies and institutional protocols.
US: The CDC Clinical Practice Guideline for Prescribing Opioids and the American Pain Society provide widely used conversion references. Many US healthcare institutions have standardized opioid conversion protocols integrated into electronic health records.
UK: The British National Formulary (BNF) and the British Pain Society provide opioid conversion guidance that may differ slightly from US guidelines in specific conversion ratios. UK clinicians should use the BNF-recommended factors for clinical decision-making.
India: Opioid prescribing in India is regulated by the Narcotics Control Bureau under the Narcotic Drugs and Psychotropic Substances Act. The Indian Council of Medical Research (ICMR) provides guidelines for pain management and opioid use. Conversion practices follow international standards with local adaptations.
This calculator is for educational and clinical reference purposes only. Always consult a healthcare professional for medical decisions regarding opioid prescribing and pain management. Do not modify a patient's medication regimen without appropriate medical supervision.
Frequently Asked Questions
What is equianalgesic opioid conversion?
Equianalgesic opioid conversion is the process of switching a patient from one opioid medication to another while maintaining the same level of pain relief. Different opioids have different potencies and bioavailability depending on the route of administration (oral, intravenous, subcutaneous, or transdermal). The equianalgesic chart provides standardized conversion ratios based on clinical studies, using 10 mg of intravenous morphine as the reference point. This calculator applies those ratios to calculate the equivalent dose of the target opioid.
How is the opioid conversion dose calculated?
The opioid conversion is calculated using the equianalgesic ratio between the source and target opioids. Each opioid and route combination has an established equivalent dose relative to 10 mg of IV morphine. For example, 30 mg of oral morphine equals 10 mg IV morphine, and 15 mg of oral oxycodone also equals 10 mg IV morphine. To convert from oral morphine to oral oxycodone: divide the source dose by its equivalence factor (30 mg per 10 mg IV morphine) and multiply by the target's equivalence factor (15 mg per 10 mg IV morphine). The result is then optionally reduced by the incomplete cross-tolerance percentage (typically 25-50%) to account for the patient's reduced tolerance to the new opioid.
What is incomplete cross-tolerance and why does it matter?
Incomplete cross-tolerance is a phenomenon where a patient who has developed tolerance to one opioid may not have full tolerance to a different opioid, even at equianalgesic doses. This occurs because different opioids act on different subtypes of opioid receptors (mu, kappa, delta) with varying affinity and efficacy. Clinical guidelines recommend reducing the calculated equivalent dose by 25-50% when switching opioids to account for incomplete cross-tolerance. This safety measure helps prevent opioid overdose during opioid rotation. The reduction percentage depends on the specific opioid pair, the patient's clinical status, and the reason for switching.
When is opioid rotation or conversion needed?
Opioid rotation is indicated when a patient experiences inadequate pain relief despite dose escalation, intolerable side effects (such as severe constipation, nausea, sedation, or cognitive impairment), or develops opioid-induced hyperalgesia. It is also used when changing the route of administration due to swallowing difficulties, when transitioning from acute to chronic pain management, or when switching from a short-acting to a long-acting formulation. Opioid conversion requires careful clinical judgment, close monitoring, and individual dose titration after the initial conversion.
What is the reference standard for equianalgesic conversion?
The reference standard for equianalgesic opioid conversion is 10 mg of intravenous (IV) morphine. All other opioids and routes are compared to this standard based on their relative potency established in clinical trials. For example, 30 mg of oral morphine is equianalgesic to 10 mg IV morphine due to oral bioavailability of approximately 30%. Similarly, 15 mg of oral oxycodone, 300 mg of oral codeine, and 4 mg of oral hydromorphone are all equivalent to 10 mg IV morphine. The equianalgesic chart used in this calculator is derived from published clinical data and widely referenced in medical literature.
Are opioid conversion factors the same worldwide?
Opioid conversion factors are generally consistent across medical guidelines worldwide, but minor variations exist. The United States commonly uses conversion factors from the CDC and major medical textbooks. The United Kingdom uses the British National Formulary (BNF) and national guidelines from organizations like the British Pain Society. In India, opioid prescribing follows guidelines from the Indian Council of Medical Research (ICMR) and the Narcotics Control Bureau. This calculator uses the widely accepted equianalgesic ratios from published clinical literature. Clinicians should always verify conversion factors against their local formularies and institutional protocols.
Can this calculator be used for all opioid conversions?
This calculator covers the most commonly prescribed opioids including morphine, oxycodone, hydromorphone, codeine, tramadol, fentanyl, buprenorphine, diamorphine, and alfentanyl across oral, intravenous, subcutaneous, and transdermal routes. However, it may not include every available opioid formulation or route of administration. Conversion factors for intravenous and epidural routes, as well as for less commonly used opioids, may require specialized clinical expertise. Always use clinical judgment and consider patient-specific factors such as age, renal function, hepatic function, and concurrent medications when performing opioid conversion.
What safety precautions should be taken during opioid conversion?
Opioid conversion requires several safety precautions: always apply a cross-tolerance reduction of 25-50% when switching between different opioids; recalculate doses when changing routes of administration; monitor the patient closely during the first 24-48 hours after conversion; provide rescue doses of short-acting opioids as needed; educate the patient and family about signs of opioid toxicity including respiratory depression, excessive sedation, and confusion; and arrange appropriate follow-up for dose titration. This calculator provides estimates only and should not replace clinical judgment or individual patient assessment. Consult a pain specialist for complex conversions.